Rodríguez López, Carmen María Author
The Effects of a Gluten-free Diet Versus a Hypocaloric Diet among Patients with Fibromyalgia Experiencing Gluten Sensitivity-like Symptoms
- Slim M.
- Calandre E.
- Garcia-Leiva J.
- Rico-Villademoros F.
- Molina-Barea R.
- Rodriguez-Lopez C.
- Morillas-Arques P.
JOURNAL OF CLINICAL GASTROENTEROLOGY - 1/1/2017
- JCR Quartile: Q3 (2017)
- SJR Quartile: Q1
- JCR Impact Factor: 2.968 (2022)
- Category normalized Impact: 1.283 (2017)
- CiteScore: 5.2 (2020)
- SJR: 1.245 (2017
- SNIP: 1.038 (2017
- JCR 5-year Impact Factor: 3.211
- JCR Categories: GASTROENTEROLOGY & HEPATOLOGY
- SJR Categories: Gastroenterology (Q1)
- Scopus
- ORCID
- Web of Science
Trends in the dispensation of antidepressant drugs over the past decade (2000–2010) in Andalusia, Spain
- González-López M.
- Rodríguez-López C.
- Parrón-Carreño T.
- Luna J.
- Del Pozo E.
Social Psychiatry and Psychiatric Epidemiology - 1/05/2015
- JCR Quartile: Q2 (2015)
- SJR Quartile: Q1
- JCR Impact Factor: 2.513 (2022)
- Category normalized Impact: 0.427 (2015)
- CiteScore: 6.2 (2020)
- SJR: 1.367 (2015
- SNIP: 1.414 (2015
- JCR 5-year Impact Factor: 2.766
- JCR Categories: PSYCHIATRY
- SJR Categories: Health (social science) (Q1); Psychiatry and Mental Health (Q1); Social Psychology (Q1); Epidemiology (Q2)
- Scopus
- ORCID
- Web of Science
The effects of gluten-free diet versus hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity symptoms: protocol for a pilot, open-label, randomized clinical trial.
- Slim M.
- Molina-Barea R.
- Garcia-Leiva J.
- Rodríguez-Lopez C.
- Morillas-Arques P.
- Rico-Villademoros F.
- Calandre E.
Contemporary clinical trials - 1/01/2015
- JCR Quartile: Q3 (2015)
- SJR Quartile: Q1
- JCR Impact Factor: 2.052 (2022)
- Category normalized Impact: 0.486 (2015)
- CiteScore: 3.3 (2020)
- SJR: 1.249 (2015
- SNIP: 0.924 (2015
- JCR 5-year Impact Factor: 2.028
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
- SJR Categories: Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1)
- Scopus
- ORCID
- Web of Science
Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: A 16-week, randomized, flexible-dose, open-label trial
- Calandre E.
- Rico-Villademoros F.
- Galán J.
- Molina-Barea R.
- Vilchez J.
- Rodriguez-Lopez C.
- Hidalgo-Tallon J.
- Morillas-Arques P.
PSYCHOPHARMACOLOGY - 1/1/2014
- SJR Quartile: Q1
- JCR Impact Factor: 3.875 (2014)
- CiteScore: 6 (2020)
- SJR: 1.955 (2014
- SNIP: 1.109 (2014
- JCR 5-year Impact Factor: 3.974
- JCR Categories: PSYCHIATRY
- SJR Categories: Pharmacology (Q1)
- Scopus
- ORCID
- Web of Science
Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: An uncontrolled, 12-week, pilot study
- Calandre E.
- Slim M.
- Garcia-Leiva J.
- Rodriguez-Lopez C.
- Torres P.
- Rico-Villademoros F.
PHARMACOPSYCHIATRY - 1/1/2014
- SJR Quartile: Q1
- JCR Impact Factor: 1.851 (2014)
- CiteScore: 7.1 (2020)
- SJR: 0.906 (2014
- SNIP: 1.152 (2014
- JCR 5-year Impact Factor: 2.171
- JCR Categories: PSYCHIATRY
- SJR Categories: Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)
- Scopus
- ORCID
- Web of Science
Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study
- Hidalgo-Tallón J.
- Menéndez-Cepero S.
- Vilchez J.
- Rodríguez-López C.
- Calandre E.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE - 1/3/2013
- JCR Quartile: Q2 (2013)
- SJR Quartile: Q1
- JCR Impact Factor: 1.518 (2013)
- Category normalized Impact: 0.615 (2013)
- CiteScore: 3.5 (2020)
- SJR: 0.519 (2013
- SNIP: 1.057 (2013
- JCR 5-year Impact Factor: 1.985
- JCR Categories: INTEGRATIVE & COMPLEMENTARY MEDICINE
- SJR Categories: Complementary and Alternative Medicine (Q1)
- Scopus
- ORCID
- Web of Science
Dimensionality, reliability, and validity of the revised fibromyalgia impact questionnaire in two spanish samples
- Luciano J.
- Aguado J.
- Serrano-Blanco A.
- Calandre E.
- Rodriguez-Lopez C.
ARTHRITIS CARE and RESEARCH - 1/10/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.039 (2013)
- CiteScore: 8.2 (2020)
- SJR: 2.501 (2013
- SNIP: 1.921 (2013
- JCR 5-year Impact Factor: 4.753
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Rheumatology (Q1)
- Scopus
- ORCID
- Web of Science
Monotherapy or combination therapy for fibromyalgia treatment
- Calandre E.
- Rico-Villademoros F.
- Rodríguez-López C.
Current Rheumatology Reports - 1/12/2012
- SJR Quartile: Q1
- JCR Impact Factor: 3.873 (2022)
- Category normalized Impact: 0.453 (2012)
- CiteScore: 6.6 (2020)
- SJR: 1.124 (2012
- SNIP: 1.104 (2012
- SJR Categories: Rheumatology (Q1)
- Scopus
- ORCID
- Web of Science
Sexual Functioning in Women and Men with Fibromyalgia
- Rico-Villademoros F.
- Calandre E.
- Rodríguez-López C.
- García-Carrillo J.
- Ballesteros J.
- Hidalgo-Tallón J.
- García-Leiva J.
Journal of Sexual Medicine - 1/1/2012
10.1111/j.1743-6109.2011.02513.x
- SJR Quartile: Q1
- JCR Impact Factor: 3.513 (2012)
- CiteScore: 4.6 (2020)
- SJR: 1.191 (2012
- SNIP: 1.377 (2012
- JCR 5-year Impact Factor: 3.077
- JCR Categories: UROLOGY & NEPHROLOGY
- SJR Categories: Obstetrics and Gynecology (Q1); Reproductive Medicine (Q1); Urology (Q1)
- Scopus
- ORCID
- Web of Science
Amisulpride in the treatment of fibromyalgia: an uncontrolled study.
- Rico-Villademoros F.
- Rodriguez-Lopez C.
- Morillas-Arques P.
- Vilchez J.
- Hidalgo J.
- Calandre E.
Clinical rheumatology - 1/09/2012
- SJR Quartile: Q2
- JCR Impact Factor: 2.037 (2012)
- CiteScore: 4.5 (2020)
- SJR: 0.817 (2012
- SNIP: 1.1 (2012
- JCR 5-year Impact Factor: 1.866
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Medicine (miscellaneous) (Q2); Rheumatology (Q2)
- Scopus
- ORCID
- Web of Science
This author has no conferences.
This author has no patents.
Pregabalin effectiveness and tolerability in the prophylactic treatment of chronic migraine (2007) 27(10) 1179 (10.1111/j.1468-2982.2007.01481.x)
- Calandre E.
- Garcia-Leiva J.
- Rodriguez-Lopez C.
- Rico-Villademoros F.
Cephalalgia - 1/1/2007
10.1111/j.1468-2982.2007.01481.x
- SJR Quartile: Q1
- CiteScore: 8.1 (2020)
- SJR: 1.143 (2007
- SNIP: 1.211 (2007
- SJR Categories: Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1)
h index
Scopus: 13
Web of Science: 14
i10 index
Scopus: 13
Web of Science: 17
Author profiles
-
ORCID
-
Scopus Author ID
Research projects at UAL
- This author has no currently assigned projects.